Table 3 The means and standard deviations of the EMG measurements for each group

ͣ Right SOL onset time related to COP onset (ms)

2.79 ± 15.66

4.98 ± 17.55

−0.41

−0.12

(−0.73 0.48)

0.679

^bRight SOL phase1 activity (%MVIC)

22.68 ± 18.52

22.93 ± 13.13

−0.64

−0.01

(−0.62 0.59)

0.516

^bRight SOL phase2 activity (%MVIC)

22.81 ± 18.02

18.91 ± 10.98

0.00

0.25

(−0.35 0.86)

1.00

^bRight SOL phase3 activity (%MVIC)

52.98 ± 57.09

40.29 ± 28.12

−0.13

0.27

(−0.33 0.88)

0.892

^bRight TA onset time related to COP onset (ms)

−2.66 ± 13.91

−7.07 ± 15.87

−0.08

0.29

(−0.32 0.89)

0.935

^bRight TA phase1 activity (%MVIC)

18.89 ± 14.85

18.04 ± 10.26

−0.11

0.06

(−0.55 0.68)

0.911

^aRight TA phase2 activity (%MVIC)

15.46 ± 10.79

14.91 ± 7.93

0.18

0.05

(−0. 55 0. 67)

0.855

^aRight TA phase3 activity (%MVIC)

16.82 ± 9.34

16.34 ± 7.67 s

0.17

0.05

(−0.56 0. 66)

0.864

^aLeft SOL onset time related to COP onset(ms)

34.15 ± 19.9

32.72 ± 17.68

0.24

0.07

(−0.53 0.68)

0.811

^bLeft SOL phase1 activity (%MVIC)

16.07 ± 15.02

16.31 ± 11.36

−0.75

−0.01

(−0.62 0.59)

0.449

^bLeft SOL phase2 activity (%MVIC)

18.71 ± 17.11

19.33 ± 11.77

−0.73

−0.04

(−0.64 0.56)

0.465

^bLeft SOL phase3 activity (%MVIC)

69.32 ± 55.28

64.40 ± 36.82

−0.13

0.10

(−0.50 0.71)

0.892

^bLeft TA onset time related to COP onset (ms)

−6.52 ± 12.25

−9.89 ± 13.35

−0.35

0.25

(−0.35 0.86)

0.725

^aLeft TA phase1 activity (%MVIC)

20.26 ± 12.82

24.91 ± 14.68

−1.06

−0.33

(−0.94 0.28)

0.293

^bLeft TA phase2 activity (%MVIC)

17.58 ± 12.20

23.07 ± 18.75

−0.89

−0.34

(−0.95 0.24)

0.372

^bLeft TA phase3 activity (%MVIC)

18.06 ± 10.92

20.65 ± 14.59

−0.51

−0.19

(−0.80 0.41)

0.607